Introducing lebrikizumab for severe atopic dermatitis in Italy may result in cost savings for the national health system, a ...

IVOSKIN, a science-driven skincare brand, officially launched its "Intensive Cica Repair Cream" in January, targeting ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

Frequent flares in atopic dermatitis predict future disease severity, highlighting the need for improved treatment strategies, as found in a new study published in JAMA Dermatology.

Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

The American Academy of Dermatology has updated its guidelines for treating and managing atopic dermatitis with topical and ...

This study examined the correlation between atopic dermatitis and the risk for chronic kidney disease using data from a Taiwanese health database.

New Taipei Municipal Tucheng Hospital Dermatologist Yang Ching-yi (楊靜宜) added that moderate to severe atopic dermatitis is ...

Treatment with dupilumab is associated with weight gain in about two thirds of adults with atopic dermatitis over 3-6 months, ...

With few real-life studies that have specifically focused on how atopic dermatitis (AD) affects patients living with the ...

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the most promising stocks according to Wall Street analysts. On June 26, ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...